Schedule 13G ownership disclosure

RIGEL PHARMACEUTICALS INC

Security class unavailable · CUSIP: 766559603

Event date: 2016-11-30

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
10,061,659
Percent of class
10.1700%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000902219-16-001253
Form type
SC 13G/A
Filer
RIGEL PHARMACEUTICALS INC
CIK
CIK 1034842
Filed
Dec 12, 2016
Reporting period
Nov 30, 2016
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub